Evidence map›Paper›PMID 36587043›Full record

ArticleScientific reports2022

Development of a high-performance open-source 3D bioprinter.

Joshua W Tashman, Daniel J Shiwarski, Adam W Feinberg

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Stem Cell Niche Concept: Search for Current Expert Consensus.International journal of molecular sciences · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Extrusion bioprinting: meeting the promise of human tissue biofabrication?Progress in biomedical engineering (Bristol, England) · 2025
    Review
  16. Article
  17. Review
  18. FRESH 3D Bioprinting of Collagen Types I, II, and III.ACS biomaterials science & engineering · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joshua W Tashman *Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Daniel J Shiwarski *Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Adam W FeinbergDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA. feinberg@andrew.cmu.edu.

Funding

Advanced Manufacturing of Regenerative Extracellular Matrix Scaffolds R01FD006582 · FDA · CARNEGIE-MELLON UNIVERSITY · PI BADYLAK, STEPHEN F., FEINBERG, ADAM WALTER · 2018 to 2020
$1.8M
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease ModelingK99HL155777 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI SHIWARSKI, DANIEL J · 2021 to 2022
$222k
3D Printed Collagen Tracheal Scaffolds with Biomimetic MicrostructureF30HL154728 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI TASHMAN, JOSHUA · 2020 to 2022
$134k
FDA HHS R01 FD006582NHLBI NIH HHS F30 HL154728NHLBI NIH HHS K99 HL155777
6 · The paper itself

Abstract

The application of 3D printing to biological research has provided the tissue engineering community with a method for organizing cells and biological materials into complex 3D structures. While many commercial bioprinting platforms exist, they are expensive, ranging from $5000 to over $1,000,000. This high cost of entry prevents many labs from incorporating 3D bioprinting into their research. Due to the open-source nature of desktop plastic 3D printers, an alternative option has been to convert low-cost plastic printers into bioprinters. Several open-source modifications have been described, but there remains a need for a user-friendly, step-by-step guide for converting a thermoplastic printer into a bioprinter using components with validated performance. Here we convert a low-cost 3D printer, the FlashForge Finder, into a bioprinter using our Replistruder 4 syringe pump and the Duet3D Duet 2 WiFi for total cost of less than $900. We demonstrate that the accuracy of the bioprinter's travel is better than 35 µm in all three axes and quantify fidelity by printing square lattice collagen scaffolds with average errors less than 2%. We also show high fidelity reproduction of clinical-imaging data by printing a scaffold of a human ear using collagen bioink. Finally, to maximize accessibility and customizability, all components we have designed for the bioprinter conversion are provided as open-source 3D models, along with instructions for further modifying the bioprinter for additional use cases, resulting in a comprehensive guide for the bioprinting field.

Indexed as

BioprintingTissue ScaffoldsCollagenHumansPlasticsPrinting, Three-DimensionalTissue EngineeringCollagenPlastics

Identifiers

PMID36587043
PMCPMC9805454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.